LeafNLP Demos
Back to explore

Report #2886948

Received Feb 26, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
39 yrs
State
NJ
Recovered
Unknown
Vaccinated
Feb 12, 2026
Onset
Feb 12, 2026
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
TDAPTDAP (BOOSTRIX)GLAXOSMITHKLINE BIOLOGICALSUNK324B2—

Symptoms (1)

Expired product administered

Symptom narrative

received an expired Tdap vaccine; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 39-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 324B2, expiry date 30-JAN-2026) for prophylaxis. On 12-FEB-2026, the patient received Boostrix. On 12-FEB-2026, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: received an expired Tdap vaccine). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.